Skip to main content
Signal8

Kosaraju Sridhar

SEC insider (Form 3/4/5 filer). CIK 0001651325. Director at 10x Genomics, Inc. (TXG) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 4, 2026. Located in PLEASANTON, CA.

Companies Kosaraju Sridhar has filed insider reports for

  • 10x Genomics, Inc. (TXG): Director
  • NEVRO CORP (NVRO): Director
Kosaraju Sridhar profile photo

Kosaraju Sridhar

CIK: 0001651325

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (80.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (20.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

10x Genomics, Inc. logo
TXG

10x Genomics, Inc.

Director
NEVRO CORP logo
NVRO

NEVRO CORP

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • 10x Genomics, Inc. logo
    TXG

    10x Genomics, Inc.

    Jun 4, 2026
    Award
    Direct
    8.8K shares-
  • 10x Genomics, Inc. logo
    TXG

    10x Genomics, Inc.

    Jun 3, 2025
    Award
    Direct
    15.4K shares-
  • NEVRO CORP logo
    NVRO

    NEVRO CORP

    Apr 3, 2025
    Disposition
    Direct
    46.6K shares-
  • NEVRO CORP logo
    NVRO

    NEVRO CORP

    Dec 31, 2024
    Award
    Direct
    4.2K shares-
  • NEVRO CORP logo
    NVRO

    NEVRO CORP

    Sep 30, 2024
    Award
    Direct
    2.8K shares-

1-5 of 5